4 results
The objective of the study is the assessment of the effect of the use of the 'free style navigator continuous monitoring system' on the glucose variability in patients with type 1 diabetes mellitus. This assessment is combined with the…
The purpose of this study is to evaluate the efficacy and safety of NIS793 in combination with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel and placebo in first-line mPDAC.This study aims to explore whether blockade of Transforming…
Safety Run-in (SRI) part:To confirm the recommended phase 2 dose (RP2D) of NIS793 or any other investigational drug(s), in combination with SOC anti-cancer therapy. In protocol amendment 1, an arm with tislelizumab has been added. In this arm, the…
This research project examines whether: -susceptibility to nocebo effects predicts future pain progression in patients with chronic widespread pain, i.e. fibromyalgia (part 1), - nocebo-related learning processes differ between patients and healthy…